BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus Reports First Quarter Financial Results

07 5 2024 06:00:01 提供 Nasdaq GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

29 4 2024 06:30:00 提供 Nasdaq GlobeNewswire

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

12 3 2024 06:30:01 提供 Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

04 3 2024 07:00:00 提供 Nasdaq GlobeNewswire

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

18 1 2024 15:15:00 提供 Nasdaq GlobeNewswire

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

12 1 2024 15:15:00 提供 Nasdaq GlobeNewswire

Bioventus Names Robert Claypoole as President and Chief Executive Officer

19 12 2023 15:30:00 提供 Nasdaq GlobeNewswire

Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

06 12 2023 07:00:00 提供 Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

07 11 2023 06:00:01 提供 Nasdaq GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023

31 10 2023 06:00:00 提供 Nasdaq GlobeNewswire

Bioventus to Present at the Cantor Global Healthcare Conference

19 9 2023 20:52:45 提供 Nasdaq GlobeNewswire

Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

06 9 2023 15:30:00 提供 Nasdaq GlobeNewswire

Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance

08 8 2023 06:30:01 提供 Nasdaq GlobeNewswire

Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference

04 8 2023 07:30:00 提供 Nasdaq GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023

01 8 2023 16:35:30 提供 Nasdaq GlobeNewswire

Bioventus Completes Divestiture of its Wound Business

23 5 2023 06:30:00 提供 Nasdaq GlobeNewswire

Bioventus Reports First Quarter Financial Results

16 5 2023 15:15:00 提供 Nasdaq GlobeNewswire

Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023

15 5 2023 16:33:04 提供 Nasdaq GlobeNewswire

Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023

11 5 2023 06:00:02 提供 Nasdaq GlobeNewswire

Bioventus Announces Divestiture of its Wound Business

10 5 2023 08:00:00 提供 Nasdaq GlobeNewswire